Quest Diagnostics, Inc’s recently made public that its SVP & General Counsel PREVOZNIK MICHAEL E unloaded Company’s shares for reported $42706.0 on Sep 26 ’25. In the deal valued at $188.13 per share,227 shares were sold. As a result of this transaction, PREVOZNIK MICHAEL E now holds 38,117 shares worth roughly $6.97 million.
Then, PREVOZNIK MICHAEL E bought 227 shares, generating $42,706 in total proceeds.
Before that, PREVOZNIK MICHAEL E sold 28,288 shares. Quest Diagnostics, Inc shares valued at $5,293,313 were divested by the SVP & General Counsel at a price of $187.12 per share. As a result of the transaction, PREVOZNIK MICHAEL E now holds 38,117 shares, worth roughly $6.97 million.
Robert W. Baird downgraded its Quest Diagnostics, Inc [DGX] rating to a Neutral from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Redburn Atlantic’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Citigroup also remained covering DGX and has decreased its forecast on March 04, 2025 with a “Neutral” recommendation from previously “Buy” rating. Leerink Partners revised its rating on January 06, 2025. It rated DGX as “an Outperform” which previously was an “a Market perform”.
Price Performance Review of DGX
On Monday, Quest Diagnostics, Inc [NYSE:DGX] saw its stock fall -0.70% to $182.78. Over the last five days, the stock has gained 2.44%. Quest Diagnostics, Inc shares have risen nearly 22.66% since the year began. Nevertheless, the stocks have risen 21.16% over the past one year.
How much short interest is there in Quest Diagnostics, Inc?
A steep rise in short interest was recorded in Quest Diagnostics, Inc stocks on 2025-09-30, growing by 79810.0 shares to a total of 4.33 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 4.25 million shares. There was a rise of 1.84%, which implies that there is a positive sentiment for the stock.
